Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer�...

Description complète

Détails bibliographiques
Auteurs principaux: Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A
Autres auteurs: International College of Geriatric Psychoneuropharmacology
Format: Journal article
Langue:English
Publié: John Wiley & Sons, Ltd. 2010
Sujets: